Rankings
▼
Calendar
VTYX
Ventyx Biosciences, Inc.
$1B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$1M
Net Income
-$17M
EPS (Diluted)
$-0.34
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$14,000
Balance Sheet
Total Assets
$245,000
Total Liabilities
$31M
Stockholders' Equity
-$31M
Cash & Equivalents
$244,000
← FY 2020
All Quarters
Q1 2021 →
VTYX Q4 2020 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
